Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 987

1.

The Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) study: baseline participant profile.

Métral M, Darling K, Locatelli I, Nadin I, Santos G, Brugger P, Kovari H, Cusini A, Gutbrod K, Tarr PE, Calmy A, Lecompte TD, Assal F, Monsch A, Kunze U, Stoeckle M, Schwind M, Schmid P, Pignatti R, Di Benedetto C, Du Pasquier R, Cavassini M; NAMACO study group; Swiss HIV Cohort Study.

HIV Med. 2019 Oct 7. doi: 10.1111/hiv.12795. [Epub ahead of print]

PMID:
31589807
2.

Lewis-Base Stabilization of the Parent Al(I) Hydride under Ambient Conditions.

Mellerup SK, Cui Y, Fantuzzi F, Schmid P, Goettel JT, Bélanger-Chabot G, Arrowsmith M, Krummenacher I, Ye Q, Engel V, Engels B, Braunschweig H.

J Am Chem Soc. 2019 Oct 11. doi: 10.1021/jacs.9b09128. [Epub ahead of print]

PMID:
31577138
3.

Concurrent validity and reliability of a mobile tracking technology to measure angular and linear movements of the neck.

Sommer BB, Weisenhorn M, Ernst MJ, Meichtry A, Rast FM, Kleger D, Schmid P, Lünenburger L, Bauer CM.

J Biomech. 2019 Sep 17:109340. doi: 10.1016/j.jbiomech.2019.109340. [Epub ahead of print]

PMID:
31558310
4.

Screening HIV-positive men who have sex with men for hepatitis C re-infection risk: is a single question on condom-use enough? A sensitivity analysis.

Künzler-Heule P, Engberg S, Battegay M, Schmidt AJ, Fierz K, Nguyen H, Kocher A, Nöstlinger C, Hampel B, Stöckle M, Béguelin C, Delaloye J, Schmid P, Flepp M, Rougement M, Braun DL, Fehr J, Nicca D; Swiss HIV Cohort Study (SHCS).

BMC Infect Dis. 2019 Sep 18;19(1):821. doi: 10.1186/s12879-019-4456-7.

5.

The molecular basis of chaperone-mediated interleukin 23 assembly control.

Meier S, Bohnacker S, Klose CJ, Lopez A, Choe CA, Schmid PWN, Bloemeke N, Rührnößl F, Haslbeck M, Bieren JE, Sattler M, Huang PS, Feige MJ.

Nat Commun. 2019 Sep 11;10(1):4121. doi: 10.1038/s41467-019-12006-x.

6.

Self-reported neurocognitive impairment in people living with HIV: Characterizing clusters of patients with similar changes in self-reported neurocognitive impairment 2013-2017 in the Swiss HIV Cohort Study.

Kusejko K, Salazar-Vizcaya L, Braun DL, Tarr PE, Bernasconi E, Doco-Lecompte T, Cavassini M, Schmid P, Du Pasquier R, Hauser C, Günthard HF, Kouyos RD; Swiss HIV Cohort Study.

Clin Infect Dis. 2019 Sep 3. pii: ciz868. doi: 10.1093/cid/ciz868. [Epub ahead of print]

PMID:
31504323
7.

Impact of disease risk on the narrative bias in vaccination risk perceptions.

Haase N, Schmid P, Betsch C.

Psychol Health. 2019 Sep 3:1-20. doi: 10.1080/08870446.2019.1630561. [Epub ahead of print]

PMID:
31480866
8.

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer: The MANTA Phase 2 Randomized Clinical Trial.

Schmid P, Zaiss M, Harper-Wynne C, Ferreira M, Dubey S, Chan S, Makris A, Nemsadze G, Brunt AM, Kuemmel S, Ruiz I, Perelló A, Kendall A, Brown J, Kristeleit H, Conibear J, Saura C, Grenier J, Máhr K, Schenker M, Sohn J, Lee KS, Shepherd CJ, Oelmann E, Sarker SJ, Prendergast A, Marosics P, Moosa A, Lawrence C, Coetzee C, Mousa K, Cortés J.

JAMA Oncol. 2019 Aug 29. doi: 10.1001/jamaoncol.2019.2526. [Epub ahead of print]

PMID:
31465093
9.

Cardiorespiratory fitness and hippocampal volume predict faster episodic associative learning in older adults.

Cole RC, Hazeltine E, Weng TB, Wharff C, DuBose LE, Schmid P, Sigurdsson G, Magnotta VA, Pierce GL, Voss MW.

Hippocampus. 2019 Aug 28. doi: 10.1002/hipo.23151. [Epub ahead of print]

PMID:
31461198
10.

The Hsp90 isoforms from S. cerevisiae differ in structure, function and client range.

Girstmair H, Tippel F, Lopez A, Tych K, Stein F, Haberkant P, Schmid PWN, Helm D, Rief M, Sattler M, Buchner J.

Nat Commun. 2019 Aug 9;10(1):3626. doi: 10.1038/s41467-019-11518-w.

11.

Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland.

Santos GMA, Locatelli I, Métral M, Calmy A, Lecompte TD, Nadin I, Hauser C, Cusini A, Hasse B, Kovari H, Tarr P, Stoeckle M, Fux C, Di Benedetto C, Schmid P, Darling KEA, Du Pasquier R, Cavassini M; Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) Study Group.

Open Forum Infect Dis. 2019 Jul 8;6(7):ofz277. doi: 10.1093/ofid/ofz277. eCollection 2019 Jul.

12.

Effective strategies for rebutting science denialism in public discussions.

Schmid P, Betsch C.

Nat Hum Behav. 2019 Sep;3(9):931-939. doi: 10.1038/s41562-019-0632-4. Epub 2019 Jun 24.

PMID:
31235861
13.

[Consequences of the temporaneous lack of admissibility of involuntary medication in the state of Baden-Wuerttemberg: not less drugs, but longer deprivation of liberty].

Steinert T, Keyssner S, Schmid P, Flammer E.

Fortschr Neurol Psychiatr. 2019 Jun 24. doi: 10.1055/a-0893-6507. [Epub ahead of print] German.

PMID:
31234213
14.

Homo naledi cranial remains from the Lesedi chamber of the rising star cave system, South Africa.

de Ruiter DJ, Laird MF, Elliott M, Schmid P, Brophy J, Hawks J, Berger LR.

J Hum Evol. 2019 Jul;132:1-14. doi: 10.1016/j.jhevol.2019.03.019. Epub 2019 Apr 28.

PMID:
31203841
15.

Close the ring to break the cycle: tandem quinolone-alkyne-cyclisation gives access to tricyclic pyrrolo[1,2-a]quinolin-5-ones with potent anti-protozoal activity.

Szamosvári D, Sylvester K, Schmid P, Lu KY, Derbyshire ER, Böttcher T.

Chem Commun (Camb). 2019 Jun 13;55(49):7009-7012. doi: 10.1039/c9cc01689a.

PMID:
31119221
16.

Electrical and Self-Sensing Properties of Alkali-Activated Slag Composite with Graphite Filler.

Rovnaník P, Kusák I, Bayer P, Schmid P, Fiala L.

Materials (Basel). 2019 May 16;12(10). pii: E1616. doi: 10.3390/ma12101616.

17.

Sr[Li2Al2O2N2]:Eu2+-A high performance red phosphor to brighten the future.

Hoerder GJ, Seibald M, Baumann D, Schröder T, Peschke S, Schmid PC, Tyborski T, Pust P, Stoll I, Bergler M, Patzig C, Reißaus S, Krause M, Berthold L, Höche T, Johrendt D, Huppertz H.

Nat Commun. 2019 Apr 23;10(1):1824. doi: 10.1038/s41467-019-09632-w.

18.

IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer.

Cortés J, André F, Gonçalves A, Kümmel S, Martín M, Schmid P, Schuetz F, Swain SM, Easton V, Pollex E, Deurloo R, Dent R.

Future Oncol. 2019 Jun;15(17):1951-1961. doi: 10.2217/fon-2019-0059. Epub 2019 Apr 12.

PMID:
30977385
19.

Self-Assembly of Short Chain Poly- N-isopropylacrylamid Induced by Superchaotropic Keggin Polyoxometalates: From Globules to Sheets.

Buchecker T, Schmid P, Grillo I, Prévost S, Drechsler M, Diat O, Pfitzner A, Bauduin P.

J Am Chem Soc. 2019 May 1;141(17):6890-6899. doi: 10.1021/jacs.8b12181. Epub 2019 Apr 18.

PMID:
30951628
20.

Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?

Bertisch B, Brezzi M, Negro F, Müllhaupt B, Ottiger C, Künzler-Heule P, Schmid P, Giudici F, Clerc O, Moriggia A, Roelens M, Marinucci F, Zehnder C, Moradpour D, Keiser O; Swiss Hepatitis C Cohort Study.

Clin Infect Dis. 2019 Apr 3. pii: ciz270. doi: 10.1093/cid/ciz270. [Epub ahead of print]

PMID:
30943286
21.

[Open doors of a psychiatric intensive care unit with addiction patients: A 3-year Follow up study].

Schmid P, Uhlmann C.

Fortschr Neurol Psychiatr. 2019 Sep;87(9):493-498. doi: 10.1055/a-0759-1809. Epub 2019 Mar 19. German.

PMID:
30891723
22.

Clusters of sexual behaviour in HIV-positive men who have sex with men reveal highly dissimilar time trends.

Salazar-Vizcaya L, Kusejko K, Schmidt AJ, Carrillo-Montoya G, Nicca D, Wandeler G, Braun DL, Fehr J, Darling KEA, Bernasconi E, Schmid P, Günthard HF, Kouyos RD, Rauch A.

Clin Infect Dis. 2019 Mar 15. pii: ciz208. doi: 10.1093/cid/ciz208. [Epub ahead of print]

23.

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply.

Schmid P, Chui SY, Emens LA.

N Engl J Med. 2019 Mar 7;380(10):987-988. doi: 10.1056/NEJMc1900150. No abstract available.

PMID:
30855757
24.

Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients.

Abela IA, Scherrer AU, Böni J, Yerly S, Klimkait T, Perreau M, Hirsch HH, Furrer H, Calmy A, Schmid P, Cavassini M, Bernasconi E, Günthard HF; Swiss HIV Cohort Study.

Clin Infect Dis. 2019 Mar 7. pii: ciz178. doi: 10.1093/cid/ciz178. [Epub ahead of print]

PMID:
30843028
25.

[Psychological antecedents of vaccination: definitions, measurement, and interventions].

Betsch C, Schmid P, Korn L, Steinmeyer L, Heinemeier D, Eitze S, Küpke NK, Böhm R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):400-409. doi: 10.1007/s00103-019-02900-6. Review. German.

PMID:
30805674
26.

[Effects of an animal-assisted intervention on psychiatric in-patient addiction treatment - a pilot study].

Uhlmann C, Nauss C, Worbs A, Pfund U, Schmid P.

Fortschr Neurol Psychiatr. 2019 May;87(5):305-311. doi: 10.1055/a-0832-8810. Epub 2019 Feb 21. German.

PMID:
30791060
27.

Mechanistic Studies of Fatty Acid Activation by CYP152 Peroxygenases Reveal Unexpected Desaturase Activity.

Pickl M, Kurakin S, Cantú Reinhard FG, Schmid P, Pöcheim A, Winkler CK, Kroutil W, de Visser SP, Faber K.

ACS Catal. 2019 Jan 4;9(1):565-577. doi: 10.1021/acscatal.8b03733. Epub 2018 Dec 6.

28.

Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination.

Betsch C, Schmid P, Heinemeier D, Korn L, Holtmann C, Böhm R.

PLoS One. 2018 Dec 7;13(12):e0208601. doi: 10.1371/journal.pone.0208601. eCollection 2018.

29.

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.

Adams S, Schmid P, Rugo HS, Winer EP, Loirat D, Awada A, Cescon DW, Iwata H, Campone M, Nanda R, Hui R, Curigliano G, Toppmeyer D, O'Shaughnessy J, Loi S, Paluch-Shimon S, Tan AR, Card D, Zhao J, Karantza V, Cortés J.

Ann Oncol. 2019 Mar 1;30(3):397-404. doi: 10.1093/annonc/mdy517.

PMID:
30475950
30.

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study.

Adams S, Loi S, Toppmeyer D, Cescon DW, De Laurentiis M, Nanda R, Winer EP, Mukai H, Tamura K, Armstrong A, Liu MC, Iwata H, Ryvo L, Wimberger P, Rugo HS, Tan AR, Jia L, Ding Y, Karantza V, Schmid P.

Ann Oncol. 2019 Mar 1;30(3):405-411. doi: 10.1093/annonc/mdy518.

PMID:
30475947
31.

Diagnostik des Karpaltunnelsyndroms: Wert der Sonografie im Vergleich zur elektrophysiologischen Untersuchung.

Schmid P, Badur N, Kluge S, Vögelin E.

Praxis (Bern 1994). 2018;107(6):309-314. doi: 10.1024/1661-8157/a003169. German.

PMID:
30426839
32.

ESMO 2018 presidential symposium-IMpassion130: atezolizumab+nab-paclitaxel in triple-negative breast cancer.

Schmid P.

ESMO Open. 2018 Oct 20;3(6):e000453. doi: 10.1136/esmoopen-2018-000453. eCollection 2018. No abstract available.

33.

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.

Grebely J, Conway B, Cunningham EB, Fraser C, Moriggia A, Gane E, Stedman C, Cooper C, Castro E, Schmid P, Petoumenos K, Hajarizadeh B, Marks P, Erratt A, Dalgard O, Lacombe K, Feld JJ, Bruneau J, Daulouede JP, Powis J, Bruggmann P, Matthews GV, Kronborg I, Shaw D, Dunlop A, Hellard M, Applegate TL, Crawford S, Dore GJ; D3FEAT Study Group.

Int J Drug Policy. 2018 Dec;62:94-103. doi: 10.1016/j.drugpo.2018.10.004. Epub 2018 Oct 29.

PMID:
30384028
34.

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Hegg R, Im SA, Shaw Wright G, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA; IMpassion130 Trial Investigators.

N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20.

PMID:
30345906
35.

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).

Kowanetz M, Zou W, Gettinger SN, Koeppen H, Kockx M, Schmid P, Kadel EE 3rd, Wistuba I, Chaft J, Rizvi NA, Spigel DR, Spira A, Hirsch FR, Cohen V, Smith D, Boyd Z, Miley N, Flynn S, Leveque V, Shames DS, Ballinger M, Mocci S, Shankar G, Funke R, Hampton G, Sandler A, Amler L, Mellman I, Chen DS, Hegde PS.

Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10119-E10126. doi: 10.1073/pnas.1802166115. Epub 2018 Oct 8.

36.

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations.

Laut KG, Shepherd L, Gottfredsson M, Sedlacek D, Knysz B, Begovac J, Radoi R, Schmied B, Chkhartishvili N, Florence E, Ristola M, Fätkenheuer G, Mulcahy F, Schmid P, Kuzovatova E, Paduta D, Smidt J, Domingo P, Szlávik J, Lundgren J, Mocroft A, Kirk O; EuroSIDA study group.

AIDS. 2018 Nov 28;32(18):2807-2819. doi: 10.1097/QAD.0000000000002035.

PMID:
30289816
37.

Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer: A Phase 1 Study.

Emens LA, Cruz C, Eder JP, Braiteh F, Chung C, Tolaney SM, Kuter I, Nanda R, Cassier PA, Delord JP, Gordon MS, ElGabry E, Chang CW, Sarkar I, Grossman W, O'Hear C, Fassò M, Molinero L, Schmid P.

JAMA Oncol. 2019 Jan 1;5(1):74-82. doi: 10.1001/jamaoncol.2018.4224.

38.

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals.

Conconi A, Zucca E, Margiotta-Casaluci G, Darling K, Hasse B, Battegay M, Staehelin C, Novak U, Schmid P, Scherrer A, Dirnhofer S, Kwee I, Nassi L, Cavalli F, Gaidano G, Bertoni F, Bernasconi E; Swiss HIV Cohort study (SHCS).

Hematol Oncol. 2018 Dec;36(5):757-764. doi: 10.1002/hon.2536. Epub 2018 Aug 16.

PMID:
30113708
39.

High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men.

Braun DL, Hampel B, Martin E, Kouyos R, Kusejko K, Grube C, Flepp M, Stöckle M, Conen A, Béguelin C, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study .

Clin Infect Dis. 2019 Feb 1;68(4):561-568. doi: 10.1093/cid/ciy545.

PMID:
30107494
40.

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men.

Braun DL, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Nicca D, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study .

Clin Infect Dis. 2019 Feb 1;68(4):569-576. doi: 10.1093/cid/ciy547.

PMID:
30107485
41.

Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers.

Winters ZE, Horsnell J, Elvers KT, Maxwell AJ, Jones LJ, Shaaban AM, Schmid P, Williams NR, Beswick A, Greenwood R, Ingram JC, Saunders C, Vaidya JS, Esserman L, Jatoi I, Brunt AM.

BJS Open. 2018 May 22;2(4):162-174. doi: 10.1002/bjs5.53. eCollection 2018 Aug. Review.

42.

Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60.

Betsch C, Rossmann C, Pletz MW, Vollmar HC, Freytag A, Wichmann O, Hanke R, Hanke W, Heinemeier D, Schmid P, Eitze S, Weber W, Reinhardt A, Küpke NK, Forstner C, Fleischmann-Struzek C, Mikolajetz A, Römhild J, Neufeind J, Rieck T, Suchecka K, Reinhart K.

BMC Public Health. 2018 Jul 16;18(1):885. doi: 10.1186/s12889-018-5787-9.

43.

Incidental Findings on Coronary Computed Tomography Angiography in Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Persons.

Reinschmidt S, Turk T, Tarr PE, Kouyos R, Hauser C, Schmid P, Weber R, Kaufmann P, Buechel RR, Kovari H; Swiss HIV Cohort Study .

Open Forum Infect Dis. 2018 Apr 20;5(5):ofy084. doi: 10.1093/ofid/ofy084. eCollection 2018 May.

44.

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients With NSCLC.

Spigel DR, Chaft JE, Gettinger S, Chao BH, Dirix L, Schmid P, Chow LQM, Hicks RJ, Leon L, Fredrickson J, Kowanetz M, Sandler A, Funke R, Rizvi NA.

J Thorac Oncol. 2018 Nov;13(11):1733-1742. doi: 10.1016/j.jtho.2018.05.004.

PMID:
29775807
45.

How baby's first shot determines the development of maternal attitudes towards vaccination.

Betsch C, Bödeker B, Schmid P, Wichmann O.

Vaccine. 2018 May 17;36(21):3018-3026. doi: 10.1016/j.vaccine.2018.04.023.

PMID:
29691102
46.

Standardized Management Protocol in Severe Postpartum Hemorrhage: A Single-Center Study.

Colucci G, Helsing K, Biasiutti FD, Raio L, Schmid P, Tsakiris DA, Eberle B, Surbek D, Lämmle B, Alberio L.

Clin Appl Thromb Hemost. 2018 Sep;24(6):884-893. doi: 10.1177/1076029618758956. Epub 2018 Apr 18.

47.

[Smoking Behaviour Among Patients and Staff of a Psychiatric Hospital: Two Independent Surveys in 2007 and 2015].

Grempler J, Steinert T, Schmid P.

Psychiatr Prax. 2019 Jan;46(1):20-26. doi: 10.1055/a-0574-6695. Epub 2018 Apr 17. German.

PMID:
29665609
48.

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.

Fearon AE, Carter EP, Clayton NS, Wilkes EH, Baker AM, Kapitonova E, Bakhouche BA, Tanner Y, Wang J, Gadaleta E, Chelala C, Moore KM, Marshall JF, Chupin J, Schmid P, Jones JL, Lockley M, Cutillas PR, Grose RP.

Cell Rep. 2018 Feb 27;22(9):2469-2481. doi: 10.1016/j.celrep.2018.02.028.

49.

Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe.

Santos JR, Cozzi-Lepri A, Phillips A, De Wit S, Pedersen C, Reiss P, Blaxhult A, Lazzarin A, Sluzhynska M, Orkin C, Duvivier C, Bogner J, Gargalianos-Kakolyris P, Schmid P, Hassoun G, Khromova I, Beniowski M, Hadziosmanovic V, Sedlacek D, Paredes R, Lundgren JD; EuroSIDA study group.

HIV Med. 2018 May;19(5):324-338. doi: 10.1111/hiv.12581. Epub 2018 Feb 1.

PMID:
29388732
50.

Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.

Traina TA, Miller K, Yardley DA, Eakle J, Schwartzberg LS, O'Shaughnessy J, Gradishar W, Schmid P, Winer E, Kelly C, Nanda R, Gucalp A, Awada A, Garcia-Estevez L, Trudeau ME, Steinberg J, Uppal H, Tudor IC, Peterson A, Cortes J.

J Clin Oncol. 2018 Mar 20;36(9):884-890. doi: 10.1200/JCO.2016.71.3495. Epub 2018 Jan 26.

Supplemental Content

Loading ...
Support Center